{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:11:40Z","timestamp":1792080700498,"version":"4.4.0"},"reference-count":153,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.pharmthera.2007.09.001","type":"journal-article","created":{"date-parts":[[2007,9,21]],"date-time":"2007-09-21T11:13:29Z","timestamp":1190373209000},"page":"105-122","source":"Crossref","is-referenced-by-count":36,"title":["The development of tolerance to drugs that suppress food intake"],"prefix":"10.1016","volume":"117","author":[{"given":"John D.","family":"Fernstrom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SuJean","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2007.09.001_bib1","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/0028-3908(95)00138-7","article-title":"Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera","volume":"34","author":"Abramowski","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib2","series-title":"Anorectic agents: mechanisms of action and tolerance","first-page":"45","article-title":"Anorectics: lack of cross tolerance among serotonergic drugs and sensitization of amphetamine's effect","author":"Antelman","year":"1981"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib3","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1037\/h0077040","article-title":"Cholecystokinin elicits the complete behavioral sequence of satiety in rats","volume":"89","author":"Antin","year":"1975","journal-title":"J Comp Physiol Psychol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0024-3205(01)01366-2","article-title":"Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats","volume":"70","author":"Arnold","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0196-9781(96)00025-3","article-title":"Leptin enters the brain by a saturable system independent of insulin","volume":"17","author":"Banks","year":"1996","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib6","series-title":"Amphetamines and Related Compounds","first-page":"21","article-title":"Structure-activity relationships in CF3 substituted phenethylamines","author":"Beregi","year":"1970"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0149-7634(95)00033-B","article-title":"Food reward: brain substrates of wanting and liking","volume":"20","author":"Berridge","year":"1996","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0166-2236(03)00233-9","article-title":"Parsing reward","volume":"26","author":"Berridge","year":"2003","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0149-7634(02)00014-3","article-title":"Multiple neural systems controlling food intake and body weight","volume":"26","author":"Berthoud","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.physbeh.2004.04.034","article-title":"Mind versus metabolism in the control of food intake and energy balance","volume":"81","author":"Berthoud","year":"2004","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.appet.2004.04.009","article-title":"Neural control of appetite: cross-talk between homeostatic and non-homeostatic systems","volume":"43","author":"Berthoud","year":"2004","journal-title":"Appetite"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib12","series-title":"Amphetamines and Related Compounds","first-page":"3","article-title":"Structure-activity relationships of amphetamine and derivatives","author":"Biel","year":"1970"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib13","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/0028-3908(84)90098-4","article-title":"Serotonin and appetite","volume":"23","author":"Blundell","year":"1984","journal-title":"Neuropharmacology"},{"issue":"Suppl","key":"10.1016\/j.pharmthera.2007.09.001_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0195-6663(86)80051-4","article-title":"Serotonin manipulations and the structure of feeding behaviour","volume":"7","author":"Blundell","year":"1986","journal-title":"Appetite"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ajcn\/71.1.3","article-title":"What foods do people habitually eat? A dilemma for nutrition, an enigma for psychology","volume":"71","author":"Blundell","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2165\/00023210-199809060-00005","article-title":"Serotonin and appetite regulation: implications for the pharmacological treatment of obesity","volume":"9","author":"Blundell","year":"1998","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib17","series-title":"Anorectic Agents: Mechanisms of Action","first-page":"19","article-title":"Behavioural flux and feeding: continuous monitoring of food intake and food selection, and the video-recording of appetitive and satiety sequences for the analysis of drug action","author":"Blundell","year":"1981"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/j.1550-8528.1996.tb00544.x","article-title":"A double-blind randomized placebo-controlled trial of sibutramine","volume":"4","author":"Bray","year":"1996","journal-title":"Obes Res"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2796.2005.01553.x","article-title":"Brain regulation of food intake and appetite: molecules and networks","volume":"258","author":"Broberger","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib20","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/sj.bjp.0704030","article-title":"Sibutramine reduces feeding, body fat and improves insulin resistance in dietary-obese male Wistar rats independently of hypothalamic neuropeptide Y","volume":"132","author":"Brown","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0028-3908(94)90067-1","article-title":"Localization of 5HT1B, 5HT1D\u03b1, 5HT1E and 5HT1F receptor messenger RNA in rodent and primate brain","volume":"33","author":"Bruinvels","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0278-5846(88)90003-6","article-title":"The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation","volume":"12","author":"Buckett","year":"1988","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00213-002-0998-1","article-title":"The melanocortin receptor agonist MTII augments the rewarding effect of amphetamine in ad-libitum-fed and food-restricted rats","volume":"161","author":"Cabeza de Vaca","year":"2002","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib23","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.peptides.2005.03.041","article-title":"Feeding, body weight, and sensitivity to non-ingestive reward stimuli during and after 12-day continuous central infusions of melanocortin receptor ligands","volume":"26","author":"Cabeza de Vaca","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0196-9781(89)90096-X","article-title":"Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami","volume":"10","author":"Calogero","year":"1989","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0091-3057(85)90417-4","article-title":"Effects of initial body weight on anorexia and tolerance to fenfluramine in rats","volume":"23","author":"Carlton","year":"1985","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib27","first-page":"825","article-title":"Long term actions of d-fenfluramine in two rat models of obesity: I. Sustained reductions in body weight and adiposity without depletion of brain serotonin","volume":"13","author":"Carlton","year":"1989","journal-title":"Int J Obes"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0031-9384(71)90287-3","article-title":"Contingent tolerance to the anorexigenic effects of amphetamine","volume":"7","author":"Carlton","year":"1971","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0006-8993(01)03330-3","article-title":"Intermittent, chronic fenfluramine administration to rats repeatedly suppresses food intake despite substantial brain serotonin reductions","volume":"928","author":"Choi","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainres.2006.02.129","article-title":"Effects of chronic fenfluramine administration on hypothalamic neuropeptide mRNA expression","volume":"1087","author":"Choi","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1210\/endo-115-1-427","article-title":"Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats","volume":"115","author":"Clark","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0149-7634(99)00074-3","article-title":"Meal patterning in rodents: psychopharmacological and neuroanatomical studies","volume":"24","author":"Clifton","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00443419","article-title":"A behavioural profile of fluoxetine-induced anorexia","volume":"97","author":"Clifton","year":"1989","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nn1455","article-title":"Anatomy and regulation of the central melanocortin system","volume":"8","author":"Cone","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-6147(96)01003-6","article-title":"Appetite suppression by commonly used drugs depends on 5HT receptors but not on 5HT availability","volume":"18","author":"Curzon","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0149-7634(99)00083-4","article-title":"Effects of selected serotonin 5HT(1) and 5HT(2) receptor agonists on feeding behavior: possible mechanisms of action","volume":"24","author":"De Vry","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib37","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s002130100804","article-title":"SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats","volume":"157","author":"Deroche-Gamonet","year":"2001","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib38","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0306-4522(95)00566-8","article-title":"The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats","volume":"72","author":"Dryden","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib39","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0196-9781(96)00142-8","article-title":"Differential effects of the 5HT 1B\/2C receptor agonist mCPP and the 5HT1A agonist flesinoxan on hypothalamic neuropeptide Y in the rat: evidence that NPY may mediate serotonin's effects on food intake","volume":"17","author":"Dryden","year":"1996","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib40","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0361-9230(92)90157-S","article-title":"Effect of d-fenfluramine on neuropeptide Y concentration and release in the paraventricular nucleus of food-deprived rats","volume":"29","author":"Dube","year":"1992","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00360-005-0009-z","article-title":"Dose-related steady states of fat loss in long-term leptin-treated ob\/ob mice: leptin resistance or desensitization versus counterregulatory signaling","volume":"175","author":"Eiden","year":"2005","journal-title":"J Comp Physiol B"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib42","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1152\/japplphysiol.01380.2004","article-title":"Homeostatic responses to caloric restriction: influence of background metabolic rate","volume":"99","author":"Evans","year":"2005","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/385165a0","article-title":"Role of melanocortinergic neurons in feeding and the agouti obesity syndrome","volume":"385","author":"Fan","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib44","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archsurg.141.3.276","article-title":"Chronic changes in blood pressure in extremely obese patients who have undergone bariatric surgery","volume":"141","author":"Fernstrom","year":"2006","journal-title":"Arch Surg"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib45","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.neubiorev.2007.03.004","article-title":"Liking vs. wanting food: importance for human appetite control and weight regulation","volume":"31","author":"Finlayson","year":"2007","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib46","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/sj.bjp.0701798","article-title":"Effect of chronic m-CPP on locomotion, hypophagia, plasma corticosterone and 5HT2C receptor levels in the rat","volume":"123","author":"Fone","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1126\/science.287.5450.125","article-title":"Modulation of brain reward circuitry by leptin","volume":"287","author":"Fulton","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib48","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1093\/ajcn\/55.1.160s","article-title":"Progress report on the anorexia induced by drugs believed to mimic some of the effects of serotonin on the central nervous system","volume":"55","author":"Garattini","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib49","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ajcn\/71.1.130","article-title":"Undereating and underrecording of habitual food intake in obese men: selective underreporting of fat intake","volume":"71","author":"Goris","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib50","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/sj.bjp.0702633","article-title":"Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigms in rats","volume":"127","author":"Grignaschi","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0304-3940(88)90419-3","article-title":"Serotonin innervation of neuropeptide Y-containing neurons in the rat arcuate nucleus","volume":"85","author":"Guy","year":"1988","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib52","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1749-6632.1987.tb36222.x","article-title":"A new approach to the treatment of obesity: a discussion","volume":"499","author":"Guy Grand","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib51","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(89)91499-2","article-title":"International trial of long-term dexfenfluramine in obesity","volume":"2","author":"Guy Grand","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib54","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1523\/JNEUROSCI.18-01-00559.1998","article-title":"Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus","volume":"18","author":"Hakansson","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib55","doi-asserted-by":"crossref","first-page":"8878","DOI":"10.1073\/pnas.94.16.8878","article-title":"Physiological response to long-term peripheral and central leptin infusion in lean and obese mice","volume":"94","author":"Halaas","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib56","first-page":"217","article-title":"Fenfluramine: evidence for a neurotoxic action on midbrain and a long-term depletion of serotonin","volume":"1","author":"Harvey","year":"1975","journal-title":"Psychopharm Commun"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib57","first-page":"3","article-title":"Fenfluramine: cumulative neurotoxicity after chronic treatment with low dosages in the rat","volume":"1","author":"Harvey","year":"1977","journal-title":"Commun Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib59","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1471-4159.1989.tb07389.x","article-title":"Antidepressant treatments, including sibutramine hydrochloride and electroconvulsive shock, decrease beta 1-but not beta 2-adrenoceptors in rat cortex","volume":"53","author":"Heal","year":"1989","journal-title":"J Neurochem"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2007.09.001_bib58","first-page":"S18","article-title":"Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine","volume":"22","author":"Heal","year":"1998","journal-title":"Int J Obes"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib60","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/sj.bjp.0702067","article-title":"A comparison of the effects on central 5HT function of sibutramine hydrochloride and other weight-modifying agents","volume":"125","author":"Heal","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib61","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF02244212","article-title":"Effects of antidepressant drugs and electroconvulsive shock on pre- and postsynaptic \u03b12-adrenoceptor function in the brain: rapid down-regulation by sibutramine hydrochloride","volume":"103","author":"Heal","year":"1991","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib62","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1126\/science.1072327","article-title":"Activation of central melanocortin pathways by fenfluramine","volume":"297","author":"Heisler","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib63","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neuron.2006.06.004","article-title":"Serotonin reciprocally regulates melanocortin neurons to modulate food intake","volume":"51","author":"Heisler","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib64","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0091-3057(01)00709-2","article-title":"Serotonin 2C receptor agonists and the behavioural satiety sequence in mice","volume":"71","author":"Hewitt","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib65","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0014-5793(89)81390-0","article-title":"Distribution of serotonin 5HT1C receptor mRNA in adult rat brain","volume":"247","author":"Hoffman","year":"1989","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib66","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib67","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/sj.bjp.0701311","article-title":"Investigation of the mechanisms underlying the hypophagic effects of the 5HT and noradrenaline reuptake inhibitor, sibutramine, in the rat","volume":"121","author":"Jackson","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib68","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/sj.bjp.0701312","article-title":"Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat","volume":"121","author":"Jackson","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib69","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","article-title":"Effect of sibutramine on weight maintenance after weight loss: a randomised trial","volume":"356","author":"James","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib70","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0306-4522(98)00523-5","article-title":"d-Fenfluramine induces serotonin-mediated Fos expression in corticotropin-releasing factor and oxytocin neurons of the hypothalamus, and serotonin-independent Fos expression in enkephalin and neurotensin neurons of the amygdala","volume":"90","author":"Javed","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib71","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1677\/joe.0.1730517","article-title":"Food conversion is transiently affected during 4-week chronic administration of melanocortin agonist and antagonist in rats","volume":"173","author":"Jonsson","year":"2002","journal-title":"J Endocrinol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib72","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(98)00097-4","article-title":"Serotonin stimulates corticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of conscious rats","volume":"243","author":"Kageyama","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib73","doi-asserted-by":"crossref","first-page":"11044","DOI":"10.1073\/pnas.190066697","article-title":"Leptin as a modulator of sweet taste sensitivities in mice","volume":"97","author":"Kawai","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib74","doi-asserted-by":"crossref","first-page":"1875S","DOI":"10.1093\/jn\/127.9.1875S","article-title":"Body weight set points: determination and adjustment","volume":"127","author":"Keesey","year":"1997","journal-title":"J Nutr"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib75","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.ps.37.020186.000545","article-title":"The regulation of body weight","volume":"37","author":"Keesey","year":"1986","journal-title":"Annu Rev Psychol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib76","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.physbeh.2005.08.066","article-title":"Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, action and reward","volume":"86","author":"Kelley","year":"2005","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib77","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0304-3940(84)90068-5","article-title":"Serotoninergic endings on VIP-neurons in the suprachiasmatic nucleus and on ACTH-neurons in the arcuate nucleus of the rat hypothalamus. A combination of high resolution autoradiography and electron microscopic immunocytochemistry","volume":"44","author":"Kiss","year":"1984","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib78","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0006-8993(88)91598-3","article-title":"Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects","volume":"443","author":"Krahn","year":"1988","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib79","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0024-3205(01)01401-1","article-title":"Role of hypothalamic neuropeptide Y (NPY) in the change of feeding behavior induced by repeated treatment of amphetamine","volume":"70","author":"Kuo","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib80","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1476-5381.1996.tb16692.x","article-title":"Effect of dexfenfluramine on the transcriptional activation of CRF and its type 1 receptor within the paraventricular nucleus of the rat hypothalamus","volume":"117","author":"Laflamme","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib81","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s002130050570","article-title":"Infusion of the serotonin1B (5HT1B) agonist CP-93,129 into the parabrachial nucleus potently and selectively reduces food intake in rats","volume":"136","author":"Lee","year":"1998","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib82","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00213-004-1864-0","article-title":"Reduced hypophagic effects of d-fenfluramine and the 5HT2C receptor agonist mCPP in 5HT1B receptor knockout mice","volume":"176","author":"Lee","year":"2004","journal-title":"Psychopharmacology (Berlin)"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2007.09.001_bib83","first-page":"S51","article-title":"Hypothalamic serotonin: pharmacological, biochemical, and behavioral analyses of its feeding-suppressive action","volume":"11","author":"Leibowitz","year":"1988","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib84","first-page":"R2222","article-title":"Sibutramine alters the central mechanisms regulating the defended body weight in diet-induced obese rats","volume":"279","author":"Levin","year":"2000","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib85","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0196-9781(84)90165-7","article-title":"Neuropeptide Y: a potent inducer of consummatory behavior in rats","volume":"5","author":"Levine","year":"1984","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib86","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0091-3057(81)90128-3","article-title":"Tolerance to anorectic drugs: pharmacological or artifactual","volume":"14","author":"Levitsky","year":"1981","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib87","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0361-9230(93)90009-Z","article-title":"Dexfenfluramine induces fos-like immunoreactivity in discrete brain regions in rats","volume":"31","author":"Li","year":"1993","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib88","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0006-8993(96)00397-6","article-title":"Effect of chronic dexfenfluramine on Fos in rat brain","volume":"728","author":"Li","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib89","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0006-8993(94)91881-3","article-title":"Reversal of dexfenfluramine-induced anorexia and c-Fos\/c-Jun expression by lesion in the lateral parabrachial nucleus","volume":"640","author":"Li","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib90","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/BF00489545","article-title":"Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study","volume":"86","author":"Liposits","year":"1987","journal-title":"Histochemistry"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib91","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1523\/JNEUROSCI.18-14-05537.1998","article-title":"Absence of fenfluramine-induced anorexia and reduced c-fos induction in the hypothalamus and central amygdaloid complex of serotonin 1b receptor knock-out mice","volume":"18","author":"Lucas","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib92","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0028-3908(89)90048-8","article-title":"The contribution of metabolites to the rapid and potent down-regulation of rat cortical \u03b2-adrenoceptors by the putative antidepressant sibutramine hydrochloride","volume":"28","author":"Luscombe","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib93","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3940(02)00345-2","article-title":"Distribution of serotonin 5-hydroxytriptamine 1B (5HT1B) receptors in the normal rat hypothalamus","volume":"328","author":"Makarenko","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib94","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1476-5381.1992.tb14457.x","article-title":"Characterization of 8-OH-DPAT-induced hypothermia in mice as a 5HT1A autoreceptor response and its evaluation as a model to selectively identify antidepressants","volume":"107","author":"Martin","year":"1992","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib95","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1053\/meta.2000.17695","article-title":"Leptin resistance is associated with hypothalamic leptin receptor mRNA and protein downregulation","volume":"49","author":"Martin","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib96","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0022-3565(24)36713-8","article-title":"Selective serotonin reuptake inhibitors dissociate fenfluramine's anorectic and neurotoxic effects: importance of dose, species and drug","volume":"281","author":"McCann","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib97","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0361-9230(91)90122-Z","article-title":"d-Fenfluramine and self-stimulation: loss of inhibitory effect in underweight rats","volume":"27","author":"McClelland","year":"1991","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib98","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0091-3057(89)90171-8","article-title":"The appetite suppressant, d-fenfluramine, decreases self-stimulation at a feeding site in the lateral hypothalamus","volume":"32","author":"McClelland","year":"1989","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib99","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1046\/j.1440-1681.2001.03493.x","article-title":"Circumventricular organs: gateways to the brainleptin receptors in hypothalamus and circumventricular organs","volume":"28","author":"Meister","year":"2001","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib100","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1124\/mi.5.5.8","article-title":"Serotonin 5HT2C receptor agonsits: potential for the treatment of obesity","volume":"5","author":"Miller","year":"2005","journal-title":"Mol Interv"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib101","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jama.282.16.1519","article-title":"The spread of the obesity epidemic in the United States, 1991\u20131998","volume":"282","author":"Mokdad","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib102","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1073\/pnas.86.17.6793","article-title":"5HT1c receptor is a prominent serotonin receptor subtype in the central nervous system","volume":"86","author":"Molineaux","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib103","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1001\/jama.282.16.1523","article-title":"The disease burden associated with overweight and obesity","volume":"282","author":"Must","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib104","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.HYP.0000094221.86888.AE","article-title":"Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials","volume":"42","author":"Neter","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib105","first-page":"51S","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults \u2014 the evidence report","volume":"6","author":"NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults","year":"1998","journal-title":"Obes Res"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib106","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1126\/science.278.5335.135","article-title":"Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein","volume":"278","author":"Ollmann","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib107","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1210\/en.2002-0148","article-title":"Leptin signaling in the hypothalamus during chronic central leptin infusion","volume":"144","author":"Pal","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib108","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","article-title":"Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: Rio-North America: a randomized controlled trial","volume":"295","author":"Pi-Sunyer","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib109","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1037\/h0077838","article-title":"Homeostatic regulation and Pavlovian conditioning in tolerance to amphetamine-induced anorexia","volume":"95","author":"Poulos","year":"1981","journal-title":"J Comp Physiol Psychol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib111","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00427624","article-title":"Effect of anorexic drugs on food intake and the micro-structure of eating in human subjects","volume":"66","author":"Rogers","year":"1979","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib110","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0196-9781(91)90007-C","article-title":"Acute fenfluramine administration reduces neuropeptide Y concentrations in specific hypothalamic regions of the rat: possible implications for the anorectic effect of fenfluramine","volume":"12","author":"Rogers","year":"1991","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib114","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0091-3057(94)90423-5","article-title":"Long-term administration of dexfenfluramine to genetically obese (ob\/ob) and lean mice: body weight and brain serotonin changes","volume":"49","author":"Rowland","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0031-9384(94)90124-4","article-title":"Tolerance to the anorectic effect of dexfenfluramine in rats: role of serotonin, cholecystokinin, and neuropeptide Y","volume":"55","author":"Rowland","year":"1994","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib112","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00429011","article-title":"Different behavioral mechanisms underlie tolerance to the anorectic effects of fenfluramine and quipazine","volume":"81","author":"Rowland","year":"1983","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib116","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0301-0082(86)90011-0","article-title":"Neurobiology of an anorectic drug: fenfluramine","volume":"27","author":"Rowland","year":"1986","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib113","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1037\/0735-7044.97.3.502","article-title":"Effect of chronic administration of fenfluramine and quipazine on body weight gain after ovariectomy and on brain serotonin receptor binding","volume":"97","author":"Rowland","year":"1983","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib118","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s002130100749","article-title":"Cross tolerance between anorectic action and induction of Fos-ir with dexfenfluramine and 5HT1B\/2C agonists in rats","volume":"156","author":"Rowland","year":"2001","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib117","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0031-9384(02)00980-0","article-title":"Effect of repeated administration of dexfenfluramine on feeding and brain Fos in mice","volume":"78","author":"Rowland","year":"2003","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib119","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1098-2396(200011)38:2<167::AID-SYN8>3.0.CO;2-W","article-title":"Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats","volume":"38","author":"Rowley","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib120","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1365-2826.2002.00840.x","article-title":"Resistance to the satiety action of leptin following chronic central leptin infusion is associated with the development of leptin resistance in neuropeptide Y neurones","volume":"14","author":"Sahu","year":"2002","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib121","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1365-2826.2005.01362.x","article-title":"Hypothalamic phosphatidylinositol 3-kinase-phosphodiesterase 3B-cyclic AMP pathway of leptin signalling is impaired following chronic central leptin infusion","volume":"17","author":"Sahu","year":"2005","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib122","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0014-2999(80)90167-3","article-title":"Repeated treatment with d-fenfluramine or metergoline alters cortex binding of 3H-serotonin and serotenergic sensitivity in rats","volume":"61","author":"Samanin","year":"1980","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib123","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0026-0495(95)90204-X","article-title":"Limitations in the assessment of dietary energy intake by self-report","volume":"44","author":"Schoeller","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib124","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1172\/JCI118891","article-title":"Identification of targets of leptin action in rat hypothalamus","volume":"98","author":"Schwartz","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib125","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/35007534","article-title":"Central nervous system control of food intake","volume":"404","author":"Schwartz","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib126","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1210\/en.2004-1663","article-title":"The effect of the melanocortin agonist, MT-II, on the defended level of body adiposity","volume":"146","author":"Seeley","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib127","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1210\/en.2003-0602","article-title":"Leptin modulates behavioral responses to sweet substances by influencing peripheral taste structures","volume":"145","author":"Shigemura","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib128","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/cpt1975175616","article-title":"Fenfluramine in man: hypophagia associated with diminished serotonin turnover","volume":"17","author":"Shoulson","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib129","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2165\/00003495-199243060-00003","article-title":"Appetite suppressants: a review","volume":"43","author":"Silverstone","year":"1992","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib130","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/BF00427820","article-title":"Differential dose-response effects of dexamphetamine sulphate on hunger, arousal and mood in human volunteers","volume":"79","author":"Silverstone","year":"1983","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib131","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0091-3057(01)00740-7","article-title":"Parabrachial infusion of d-fenfluramine reduces food intake. Blockade by the 5HT(1B) antagonist SB-216641","volume":"71","author":"Simansky","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib132","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1056\/NEJMoa035622","article-title":"Lifestyle, diabetes, and cardiovascular risk factors 10\u00a0years after bariatric surgery","volume":"351","author":"Sj\u00f6str\u00f6m","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ddr.430260102","article-title":"Long-term use of appetite suppressant medication: rationale and recommendations","volume":"26","author":"Stallone","year":"1992","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib134","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/0024-3205(84)90032-8","article-title":"Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus","volume":"35","author":"Stanley","year":"1984","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib135","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/oby.2002.27","article-title":"Regulation of body weight and carcass composition by sibutramine in rats","volume":"10","author":"Strack","year":"2002","journal-title":"Obes Res"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib136","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/0024-3205(82)90445-3","article-title":"Anorectic agents lower a body weight set point","volume":"30","author":"Stunkard","year":"1982","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib137","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0163-7258(87)90057-X","article-title":"Neuropharmacology of drugs affecting food intake","volume":"32","author":"Sugrue","year":"1987","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib138","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000123454","article-title":"Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study","volume":"36","author":"Swanson","year":"1983","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib139","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.brainres.2005.10.092","article-title":"Medial parabrachial nucleus neurons modulate d-fenfluramine-induced anorexia through 5HT2C receptors","volume":"1067","author":"Trifunovic","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib142","first-page":"377","article-title":"Serotonin receptor ligands and the treatment of obesity","volume":"5","author":"Vickers","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib141","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s002130050952","article-title":"Reduced satiating effect of d-fenfluramine in serotonin 5HT(2C) receptor mutant mice","volume":"143","author":"Vickers","year":"1999","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib140","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/sj.bjp.0703443","article-title":"Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats","volume":"130","author":"Vickers","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib143","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0028-3908(01)00063-6","article-title":"Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5HT2C receptors","volume":"41","author":"Vickers","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib144","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00213-002-1378-6","article-title":"Oral administration of the 5HT2C receptor agonist, mCPP, reduces body weight gain in rats over 28\u00a0days as a result of maintained hypophagia","volume":"167","author":"Vickers","year":"2003","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00213-002-1384-8","article-title":"Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa\/fa) compared to lean Zucker rats","volume":"167","author":"Vickers","year":"2003","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib146","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/clpt.1992.68","article-title":"Long-term weight control: The National Heart, Lung, and Blood Institute funded multimodal intervention study","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib147","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archinte.144.6.1143","article-title":"A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination","volume":"144","author":"Weintraub","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib148","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0091-3057(03)00045-5","article-title":"Effects of preexposure to dexfenfluramine, phentermine, dexfenfluramine\u2013phentermine, or fluoxetine on sibutramine-induced hypophagia in the adult rat","volume":"75","author":"Wellman","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib149","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/jama.286.11.1331","article-title":"Long-term weight loss with sibutramine: a randomized controlled trial","volume":"286","author":"Wirth","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/cne.20689","article-title":"Forebrain substrates of reward and motivation","volume":"493","author":"Wise","year":"2005","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib151","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0149-7634(99)00070-6","article-title":"Contingent tolerance to amphetamine hypophagia: new insights into the role of environmental context in the expression of stereotypy","volume":"24","author":"Wolgin","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib152","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/appe.2001.0483","article-title":"Effects of chronic amphetamine on the appetitive and consummatory phases of feeding","volume":"38","author":"Wolgin","year":"2002","journal-title":"Appetite"},{"key":"10.1016\/j.pharmthera.2007.09.001_bib153","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1126\/science.280.5368.1378","article-title":"Signals that regulate food intake and energy homeostasis","volume":"280","author":"Woods","year":"1998","journal-title":"Science"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372580700188X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372580700188X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T04:12:15Z","timestamp":1737432735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016372580700188X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":153,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S016372580700188X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2007.09.001","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}